Govt Job for Medical Physicist at AIIMS

All India Institute of Medical Sciences, New Delhi will conduct walk-in interview to fill up the post of Medical Physicist on CONTRACTUAL BASIS for a period of six months or till such time the alternative arrangements are made, whichever is earlier, as per following schedule.

Post : Medical Physicist (Nuclear Medicine) for NCL. Jhajjar. Haryana

No. of posts & Reservation : 01 UR

Qualification/ Experience :
Essential
i.  M.Sc. Nuclear Medicine Technology from a recognized University / Institution, and
ii. RSO Level – U certification recognized by AERB
Desirable : Ph.D in Nuclear Medicine

Upper Age limit : 35 years

Monthly Remuneration : Rs.58,000/- per month (consolidated)

Terms & Conditions
1. The appointment is purely on CONTRACT BASIS for a period of 06 months or till such time the regular appointments against this vacant post is made, whichever is earlier, with effect from the date of joining. If the contract is not extended further, the same will lapse automatically. The appointment can also be terminated at any time, on either side by giving one ™nth ® notice or by paying one month’s salary without assigning any reason or failure to complete the period of three months to the satisfaction of competent authority.

2. The consolidated remuneration for the posts of Medical Physicist (Nuclear Medicine) will be Rs 58,000/- Per month.

3. The appointee shall perform the duties as assigned to him/her. The competent authority reserves the right to assign any duty as and when required. No extra/additional allowances will be admissible in case of such assignment.

4. The appointee shall not be entitled to any benefit like Provident Fund, Pension, Gratuity, Medical Attendance Treatment, Seniority, Promotion etc. or any other benefits available to the Government Servants, appointed on regular basis.

5. The appointee shall not be granted any claim or right for regular appointment to any post of AIIMS.

6. The appointee shall be on the whole time appointment of the AIIMS and shall not accept any other assignment, paid or otherwise and shall not engage himself/herself in a private practice of any kind during the period of contract.

7. The appointment to the said post will be subject to medical fitness from the competent medical board for which he/she will be sent to the designated Medical Authority.

8. Leave entitlement of the appointee shall be governed in terms of instructions contained in DoP&T’S O.M. No. 12016/3/84- Estt.(L) dated the 12th April, 1985 as amended from time to time.

9. In case of SC/ST/OBC candidates a valid certificate, to this effect from the Competent Authority in the prescribed proforma is required. OBC candidates must submit the valid caste certificate on the last date of submission of online application i.e. 05.01.2020. As per central list of Government of India in the proforma provided by the DoPT, Govt. of India vide O.M. No. 36036/2/2013-Estt. (Res.) dated 30.05.2014.

10. On appointment, the appointee will be required to take an oath of allegiance to the Constitution of India or make a solemn affirmation to that effect in the prescribed proforma.

11. The appointee is not entitled to any T.A. for attending the interview and joining the appointment.

12. The appointee shall not be entitled to avail any allowances/facilities being extended to the regular/permanent employees of the AIIMS.

13. Other conditions of service will be governed by relevant rules and orders issued from time to time.

14. Interested candidates may apply for the post under reference in the prescribed application form available in the Institute website appending therewith copies of self-attested Certificates/testimonials and other relevant documents etc. and to bring at the time of walk-in-interview.

15. If any declaration given or information furnished by him/her proves false or if he /she is found to have willfully suppressed any material, information, he/she will be liable for removal from service and also such other action as the Government may deem necessary.

16. If any candidate is found canvassing for his/her selection, he/she will be disqualified for being called for interview/being selected.

17. The AIIMS, New Delhi reserves the rights to increase or decrease the number of vacancies. is. The applicants are required to submit soft copy (Microsoft Word) of his/ her details in the Prescribed Proforma enclosed at Annexed-I on or before 20.10.2021 at recruitmentcell@aiims.edu.

19. In case of large number of applicants, the Institute may conduct the interviews over 2-3 days or hold a screening test or adopt any other criteria deemed appropriate to shortlist the candidates. The decision of Institute authorities will be final and no correspondence what so ever will be entertained in this connection.

20. The decision of the Competent Authority regarding selection of the candidate will be final and no representations will be entertained in this regard.

Date of Interview : 26.10.2021 (Tuesday)
Reporting Time : 08.30 A.Wl. to 09,00 A.M.
Venue for Reporting : Director’s Committee Room, AIIMS, New Delhi

Related Posts

  • Pharma
  • April 16, 2024
  • 32 views
Significant Decline In Pharma Deals In Q1

NEW DELHI: The pharma and healthcare sector witnessed a significant 15% decline in volume in the first quarter this year, with 47 deals amounting to $ 409 million, as against the…

  • Pharma
  • April 16, 2024
  • 23 views
Rise In AMR Is Leaving Doctors With Fewer Options In Drugs

Ahmedabad: Imagine a bacterial infection with no known cure — a relentless adversary that defies conventional treatments and leads to prolonged illness and hospitalization. This was the condition of nine people…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Significant Decline In Pharma Deals In Q1

Significant Decline In Pharma Deals In Q1

Rise In AMR Is Leaving Doctors With Fewer Options In Drugs

Rise In AMR Is Leaving Doctors With Fewer Options In Drugs

CDSCO Releases Draft Guidance To Align New Drugs And Clinical Trials Rules And SUGAM For Stakeholder’s Comments

CDSCO Releases Draft Guidance To Align New Drugs And Clinical Trials Rules And SUGAM For Stakeholder’s Comments

Glenmark recalls 6,528 bottles of BP drug in US

Glenmark recalls 6,528 bottles of BP drug in US

Pharma Exports To US Surges 15% In 11 Months Of FY24

Pharma Exports To US Surges 15% In 11 Months Of FY24

CAHO Naa Patients Se Pyaar Hai

CAHO Naa Patients Se Pyaar Hai